Jyothy Labs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
JYOTHYLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jyothy Labs reported Q1 FY26 revenue from operations of Rs 75,121 lacs, a marginal 1.4% rise over Rs 74,118 lacs in Q1 FY25. Net profit declined about 5% to Rs 9,679 lacs from Rs 10,183 lacs, with EPS at Rs 2.64 versus Rs 2.77 last year. Fabric Care and Personal Care posted healthy growth, while the Household Insecticides segment continued to drag with a Rs 483 lacs loss and ~9.7% revenue decline. The statutory auditors BSR & Co. LLP issued a clean limited review report with no qualifications. The company has now become a standalone entity after selling its Bangladesh subsidiary earlier, which had resulted in a Rs 370 lacs exceptional loss booked in Q4 FY25.
Flat top-line growth and a slight dip in profits suggest near-term margin pressure, particularly from the Insecticides segment. The clean audit report and standalone structure remove prior overhang from the Bangladesh subsidiary sale, but investors may watch for sustained recovery in Household Insecticides.